Trial Profile
Epidemiology Study to Assess the Safety of a New Slow-release Form of Seroquel (Quetiapine) in the Post-marketing Phase in the UK
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Apr 2014
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary) ; Antidepressants; Antipsychotics
- Indications Bipolar depression; Major depressive disorder; Schizophrenia
- Focus Adverse reactions
- Acronyms GPRD-SeroquelS
- Sponsors AstraZeneca
- 06 Feb 2014 Status changed from recruiting to completed according to ClinicalTrials.gov record.
- 07 Oct 2011 New trial record